Evidence map›Paper›PMID 39479944›Full record

ArticleEuropean journal of rheumatology2024

Comparison and Significance of Contrast-Enhanced Computed Tomographic Findings of Large-Vessel Vasculitis Before and After Treatment: Differences Between Takayasu Arteritis and Giant Cell Arteritis.

Daiki Nakagomi, Tatsuya Shimizu, Shunsuke Furuta, Takahiro Sugiyama, Kei Kobayashi, Yoshiaki Kobayashi, Shunichiro Hanai, Kimie Harama, Takeyuki Kanzaki, Chisaki Ajima and 3 more

Abstract read
In one paragraph

Article in European journal of rheumatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Management of Takayasu Arteritis - A 2026 Update.Current rheumatology reports · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Daiki NakagomiDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Tatsuya ShimizuDepartment of Radiology, University of Yamanashi Hospital, Yamanashi, Japan.
Shunsuke FurutaDepartment of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
Takahiro SugiyamaDepartment of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.
Kei KobayashiDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Yoshiaki KobayashiDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Shunichiro HanaiDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Kimie HaramaDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Takeyuki KanzakiDepartment of Rheumatology, Yamanashi Prefectural Central Hospital, Yamanashi, Japan.
Chisaki AjimaDepartment of Rheumatology, University of Yamanashi Hospital, Yamanashi, Japan.
Takao SugiyamaDepartment of Rheumatology, Shimoshizu Hospital, Chiba, Japan.
Hiroshi OnishiDepartment of Radiology, University of Yamanashi Hospital, Yamanashi, Japan.
Hiroshi NakajimaDepartment of Allergy and Clinical Immunology, Chiba University Hospital, Chiba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Imaging is essential for diagnosing large-vessel vasculitis (LVV). During diagnostic imaging, assessing disease activity and vascular damage separately is important. Acute-phase findings represent disease activity, while chronic-phase findings represent vascular damage; however, whether the imaging findings are acute or chronic may be unclear. We investigated how vascular lesions change before and after treatment and whether they were acute- or chronic-phase findings. Methods: Fifty-one patients with LVV who had undergone contrast-enhanced computed tomography (CT) scans from the neck to the pelvis before treatment and 1-4 months after treatment were recruited. Wall thickening, wall contrast enhancement, stenosis, occlusion, dilation, aneurysm, and calcification were semi-quantitatively assessed in 21 vessels from the common carotid to the common iliac artery. Results: Twenty-four patients were diagnosed with Takayasu arteritis (TAK), and 27 with giant cell arteritis (GCA). Wall thickening and wall contrast enhancement improved after the treatment, which was especially significant in the GCA group. No significant differences in stenosis, occlusion, dilation, aneurysm, or calcification were observed before and after treatment. Stenosis and occlusion were more common with TAK, while calcification was more common with GCA. Conclusion: Wall thickening and wall contrast enhancement are acute-phase findings (activity), while stenosis, occlusion, dilation, aneurysm, and calcification are chronic-phase findings (damage). The frequencies of these findings differ between TAK and GCA.

Indexed as

Contrast-enhanced CTgiant cell arteritisimaginglarge-vessel vasculitisTakayasu arteritis

Identifiers

PMID39479944
PMCPMC11562625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.